
Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.
Ameren reports after the market close, meaning Day 0 reflects anticipatory trading before results are released, while Day +1 captures the market's first full reaction to the actual numbers.
| Earnings Date | Day 0 Move | Day 0 Range | Day +1 Move | Day +1 Range |
|---|---|---|---|---|
| 2026-07-30 | -$1.22 (-1.11%) | $2.98 (2.71%) | +$0.86 (+0.79%) | $3.06 (2.81%) |
| 2026-05-05 | -$0.75 (-0.67%) | $1.77 (1.57%) | -$2.05 (-1.84%) | $3.50 (3.14%) |
| 2026-02-11 | +$0.24 (+0.23%) | $1.60 (1.51%) | +$3.32 (+3.13%) | $3.84 (3.62%) |
| 2025-11-05 | -$0.63 (-0.62%) | $1.48 (1.45%) | +$0.73 (+0.72%) | $3.21 (3.17%) |
| 2025-07-31 | +$1.29 (+1.29%) | $2.12 (2.12%) | +$0.98 (+0.97%) | $2.79 (2.76%) |
| 2025-05-01 | -$1.15 (-1.16%) | $1.71 (1.72%) | +$1.39 (+1.42%) | $3.97 (4.05%) |
| 2025-02-13 | +$1.01 (+1.04%) | $1.30 (1.34%) | -$0.20 (-0.20%) | $3.21 (3.27%) |
| 2024-11-06 | +$0.11 (+0.13%) | $1.74 (1.98%) | -$1.22 (-1.39%) | $2.78 (3.17%) |
| Avg Abs Move | 0.78% | 1.80% | 1.31% | 3.25% |
Ameren's post-earnings price behavior has been relatively muted compared to many stocks, with an average absolute Day 0 move of 0.78% and Day +1 move of 1.31%. The Day 0 trading range averages 1.80%, while Day +1 sees a wider 3.25% range as the market digests the results.
The most recent earnings release on July 30, 2026, saw the stock decline 1.11% on Day 0, followed by a modest 0.79% gain on Day +1, with a relatively tight 2.71% Day 0 range expanding to 2.81% on Day +1. This pattern of initial weakness followed by recovery has appeared in several recent quarters.
The largest Day +1 move in the dataset came after the February 2026 report, when the stock surged 3.13% following a modest 0.23% Day 0 gain. Conversely, the May 2026 report produced the most significant Day +1 decline of 1.84% after a 0.67% Day 0 drop.
The data suggests that Ameren's earnings reactions tend to be relatively contained, with the stock rarely making dramatic moves in either direction. The wider Day +1 ranges indicate that investors take time to digest the details of the report and management commentary before establishing a clear directional bias.
| Metric | Value |
|---|---|
| Expiration Date | 11/20/26 (DTE 16) |
| Expected Move | $1.27 (1.12%) |
| Expected Range | $111.83 to $114.37 |
| Implied Volatility | 22.25% |
The options market is pricing in an expected move of 1.12% for the November 20 expiration, which is notably lower than Ameren's average historical Day 0 move of 0.78% and significantly below the average Day +1 move of 1.31%. This suggests options traders are anticipating a relatively subdued reaction to the earnings release, consistent with the stock's recent pattern of contained post-earnings volatility. The 1.12% expected move also falls well below the average Day +1 range of 3.25%, indicating the market is pricing in less uncertainty than historical patterns would suggest.
Ameren currently holds a Buy consensus among analysts, with 10 Strong Buy ratings, 0 Moderate Buy ratings, and 8 Hold ratings. There are no Sell or Strong Sell ratings among the 18 analysts covering the stock. The average recommendation score of 4.11 reflects solid bullish sentiment, though this has deteriorated slightly from 4.18 one month ago, when the analyst count was 10 Strong Buys and 7 Holds.
The average price target stands at $115.06, implying approximately 1.8% upside from the current level. Price targets range from a low of $104.00 to a high of $126.00, showing a relatively tight distribution that suggests analysts have converging views on the company's valuation. The modest upside to the mean target indicates that much of the positive fundamental story may already be reflected in the current price.
The slight deterioration in sentiment over the past month—with one analyst moving from Strong Buy to Hold—may reflect concerns about regulatory headwinds, rising operating costs, or valuation after the stock's recent strength. Despite this modest shift, the absence of any Sell ratings and the 10-to-8 ratio of Strong Buys to Holds demonstrates that the analyst community remains constructive on Ameren's long-term prospects, supported by the company's substantial infrastructure investment program and exposure to data center demand growth.
Ameren's technical setup heading into earnings is notably strong. The Barchart Technical Opinion currently shows a Buy signal at 8%, a dramatic improvement from a Sell signal at 24% one week ago and a Sell signal at 88% one month ago. This sharp reversal suggests significant short-term momentum has developed.
Timeframe Analysis:
The trend is characterized as Weak in strength with Average direction, suggesting the recent improvement in technical momentum is still developing and lacks the conviction of a fully established uptrend.
| Period | Value | Period | Value |
|---|---|---|---|
| 5-Day MA | $111.12 | 50-Day MA | $104.68 |
| 10-Day MA | $109.74 | 100-Day MA | $107.79 |
| 20-Day MA | $107.01 | 200-Day MA | $108.52 |
The stock is trading above all major moving averages, with the current price above the 5-day ($111.12), 10-day ($109.74), 20-day ($107.01), 50-day ($104.68), 100-day ($107.79), and 200-day ($108.52) moving averages. This alignment indicates positive momentum across all timeframes. The stock has gained approximately 8% from its 50-day moving average, suggesting a strong recent rally. The technical setup is supportive heading into earnings, with the stock in a clear uptrend and trading near recent highs. However, the "Weak" trend strength characterization and the medium-term 50% Sell signal suggest some caution is warranted—the stock may be vulnerable to profit-taking if results or guidance disappoint. Conversely, a strong beat could provide the catalyst to break the stock decisively higher and establish a more robust uptrend.